nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiludronate—PTPN1—prostate gland—prostate cancer	0.0307	0.163	CbGeAlD
Tiludronate—PTPN1—seminal vesicle—prostate cancer	0.026	0.138	CbGeAlD
Tiludronate—Congenital anomaly—Estramustine—prostate cancer	0.0215	0.0544	CcSEcCtD
Tiludronate—Developmental delay—Estramustine—prostate cancer	0.0215	0.0544	CcSEcCtD
Tiludronate—PTPN1—renal system—prostate cancer	0.021	0.111	CbGeAlD
Tiludronate—PTPN1—urethra—prostate cancer	0.0206	0.109	CbGeAlD
Tiludronate—ATP6V1A—prostate gland—prostate cancer	0.0184	0.0977	CbGeAlD
Tiludronate—PTPN1—testis—prostate cancer	0.0135	0.0719	CbGeAlD
Tiludronate—ATP6V1A—renal system—prostate cancer	0.0126	0.0666	CbGeAlD
Tiludronate—ATP6V1A—urethra—prostate cancer	0.0123	0.0654	CbGeAlD
Tiludronate—PTPN1—lymph node—prostate cancer	0.00982	0.0521	CbGeAlD
Tiludronate—ATP6V1A—bone marrow—prostate cancer	0.00949	0.0504	CbGeAlD
Tiludronate—ATP6V1A—testis—prostate cancer	0.00811	0.0431	CbGeAlD
Tiludronate—Congenital anomaly—Estradiol—prostate cancer	0.00759	0.0192	CcSEcCtD
Tiludronate—Developmental delay—Estradiol—prostate cancer	0.00759	0.0192	CcSEcCtD
Tiludronate—Bone pain—Nilutamide—prostate cancer	0.00756	0.0191	CcSEcCtD
Tiludronate—Influenza-like symptoms—Bicalutamide—prostate cancer	0.00732	0.0185	CcSEcCtD
Tiludronate—Influenza like illness—Degarelix—prostate cancer	0.00629	0.0159	CcSEcCtD
Tiludronate—Influenza-like symptoms—Ethinyl Estradiol—prostate cancer	0.00619	0.0157	CcSEcCtD
Tiludronate—ATP6V1A—lymph node—prostate cancer	0.00588	0.0312	CbGeAlD
Tiludronate—Bone pain—Bicalutamide—prostate cancer	0.00546	0.0138	CcSEcCtD
Tiludronate—Influenza like illness—Bicalutamide—prostate cancer	0.00508	0.0129	CcSEcCtD
Tiludronate—Developmental delay—Capecitabine—prostate cancer	0.00473	0.012	CcSEcCtD
Tiludronate—Congenital anomaly—Capecitabine—prostate cancer	0.00473	0.012	CcSEcCtD
Tiludronate—Influenza like illness—Ethinyl Estradiol—prostate cancer	0.00429	0.0109	CcSEcCtD
Tiludronate—Influenza-like symptoms—Estradiol—prostate cancer	0.00404	0.0102	CcSEcCtD
Tiludronate—Bone pain—Goserelin—prostate cancer	0.0038	0.00962	CcSEcCtD
Tiludronate—Rhinitis—Nilutamide—prostate cancer	0.00365	0.00924	CcSEcCtD
Tiludronate—Back pain—Nilutamide—prostate cancer	0.00306	0.00776	CcSEcCtD
Tiludronate—Bone pain—Estradiol—prostate cancer	0.00301	0.00762	CcSEcCtD
Tiludronate—Myalgia—Abiraterone—prostate cancer	0.00295	0.00747	CcSEcCtD
Tiludronate—Arthralgia—Estrone—prostate cancer	0.0029	0.00735	CcSEcCtD
Tiludronate—Bone pain—Mitoxantrone—prostate cancer	0.00281	0.0071	CcSEcCtD
Tiludronate—Influenza like illness—Estradiol—prostate cancer	0.0028	0.00709	CcSEcCtD
Tiludronate—Back pain—Degarelix—prostate cancer	0.00274	0.00693	CcSEcCtD
Tiludronate—Rhinitis—Bicalutamide—prostate cancer	0.00263	0.00667	CcSEcCtD
Tiludronate—Back pain—Cabazitaxel—prostate cancer	0.00258	0.00653	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Abiraterone—prostate cancer	0.00258	0.00653	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Estrone—prostate cancer	0.00254	0.00642	CcSEcCtD
Tiludronate—Dyspepsia—Abiraterone—prostate cancer	0.00249	0.00631	CcSEcCtD
Tiludronate—Arthralgia—Degarelix—prostate cancer	0.00241	0.0061	CcSEcCtD
Tiludronate—Vertigo—Cabazitaxel—prostate cancer	0.00239	0.00606	CcSEcCtD
Tiludronate—Pain—Estrone—prostate cancer	0.00238	0.00603	CcSEcCtD
Tiludronate—Dyspepsia—Nilutamide—prostate cancer	0.00228	0.00576	CcSEcCtD
Tiludronate—Arthralgia—Cabazitaxel—prostate cancer	0.00227	0.00575	CcSEcCtD
Tiludronate—Myalgia—Cabazitaxel—prostate cancer	0.00227	0.00575	CcSEcCtD
Tiludronate—Rhinitis—Ethinyl Estradiol—prostate cancer	0.00223	0.00564	CcSEcCtD
Tiludronate—Back pain—Bicalutamide—prostate cancer	0.00221	0.0056	CcSEcCtD
Tiludronate—Pain—Nilutamide—prostate cancer	0.00221	0.0056	CcSEcCtD
Tiludronate—Abdominal pain—Estrone—prostate cancer	0.0022	0.00557	CcSEcCtD
Tiludronate—Dyspepsia—Estradiol valerate/Dienogest—prostate cancer	0.00214	0.00541	CcSEcCtD
Tiludronate—Gastrointestinal pain—Nilutamide—prostate cancer	0.00211	0.00535	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Degarelix—prostate cancer	0.0021	0.00533	CcSEcCtD
Tiludronate—Pain—Estradiol valerate/Dienogest—prostate cancer	0.00208	0.00526	CcSEcCtD
Tiludronate—Abdominal pain—Nilutamide—prostate cancer	0.00204	0.00517	CcSEcCtD
Tiludronate—Asthenia—Abiraterone—prostate cancer	0.00203	0.00514	CcSEcCtD
Tiludronate—Diarrhoea—Estramustine—prostate cancer	0.00199	0.00505	CcSEcCtD
Tiludronate—Gastrointestinal pain—Estradiol valerate/Dienogest—prostate cancer	0.00199	0.00503	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Cabazitaxel—prostate cancer	0.00198	0.00502	CcSEcCtD
Tiludronate—Pain—Degarelix—prostate cancer	0.00197	0.005	CcSEcCtD
Tiludronate—Myalgia—Bicalutamide—prostate cancer	0.00195	0.00493	CcSEcCtD
Tiludronate—Bone pain—Docetaxel—prostate cancer	0.00194	0.00491	CcSEcCtD
Tiludronate—Diarrhoea—Abiraterone—prostate cancer	0.00194	0.0049	CcSEcCtD
Tiludronate—Abdominal pain—Estradiol valerate/Dienogest—prostate cancer	0.00192	0.00486	CcSEcCtD
Tiludronate—Dyspepsia—Cabazitaxel—prostate cancer	0.00191	0.00485	CcSEcCtD
Tiludronate—Gastrointestinal pain—Degarelix—prostate cancer	0.00189	0.00478	CcSEcCtD
Tiludronate—Bone pain—Capecitabine—prostate cancer	0.00188	0.00475	CcSEcCtD
Tiludronate—Back pain—Ethinyl Estradiol—prostate cancer	0.00187	0.00473	CcSEcCtD
Tiludronate—Pain—Cabazitaxel—prostate cancer	0.00186	0.00471	CcSEcCtD
Tiludronate—Asthenia—Nilutamide—prostate cancer	0.00185	0.0047	CcSEcCtD
Tiludronate—Asthenia—Flutamide—prostate cancer	0.00185	0.00467	CcSEcCtD
Tiludronate—Dizziness—Estrone—prostate cancer	0.00184	0.00466	CcSEcCtD
Tiludronate—Rhinitis—Goserelin—prostate cancer	0.00183	0.00464	CcSEcCtD
Tiludronate—Abdominal pain—Degarelix—prostate cancer	0.00183	0.00462	CcSEcCtD
Tiludronate—Headache—Estramustine—prostate cancer	0.00183	0.00462	CcSEcCtD
Tiludronate—Rhinitis—Conjugated Estrogens—prostate cancer	0.00181	0.00459	CcSEcCtD
Tiludronate—Influenza like illness—Docetaxel—prostate cancer	0.0018	0.00457	CcSEcCtD
Tiludronate—Gastrointestinal pain—Cabazitaxel—prostate cancer	0.00178	0.0045	CcSEcCtD
Tiludronate—Diarrhoea—Nilutamide—prostate cancer	0.00177	0.00448	CcSEcCtD
Tiludronate—Diarrhoea—Flutamide—prostate cancer	0.00176	0.00446	CcSEcCtD
Tiludronate—Influenza like illness—Capecitabine—prostate cancer	0.00175	0.00442	CcSEcCtD
Tiludronate—Headache—Estrone—prostate cancer	0.00174	0.00441	CcSEcCtD
Tiludronate—Asthenia—Estradiol valerate/Dienogest—prostate cancer	0.00174	0.00441	CcSEcCtD
Tiludronate—Nausea—Estramustine—prostate cancer	0.00173	0.00438	CcSEcCtD
Tiludronate—Abdominal pain—Cabazitaxel—prostate cancer	0.00172	0.00435	CcSEcCtD
Tiludronate—Dizziness—Nilutamide—prostate cancer	0.00171	0.00433	CcSEcCtD
Tiludronate—Dizziness—Flutamide—prostate cancer	0.0017	0.00431	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Bicalutamide—prostate cancer	0.0017	0.0043	CcSEcCtD
Tiludronate—Asthenia—Degarelix—prostate cancer	0.00166	0.00419	CcSEcCtD
Tiludronate—Nausea—Estrone—prostate cancer	0.00165	0.00419	CcSEcCtD
Tiludronate—Dyspepsia—Bicalutamide—prostate cancer	0.00164	0.00416	CcSEcCtD
Tiludronate—Headache—Nilutamide—prostate cancer	0.00162	0.0041	CcSEcCtD
Tiludronate—Headache—Flutamide—prostate cancer	0.00161	0.00408	CcSEcCtD
Tiludronate—Dizziness—Estradiol valerate/Dienogest—prostate cancer	0.00161	0.00407	CcSEcCtD
Tiludronate—Pain—Bicalutamide—prostate cancer	0.0016	0.00404	CcSEcCtD
Tiludronate—Diarrhoea—Degarelix—prostate cancer	0.00158	0.004	CcSEcCtD
Tiludronate—Asthenia—Cabazitaxel—prostate cancer	0.00156	0.00395	CcSEcCtD
Tiludronate—Back pain—Goserelin—prostate cancer	0.00154	0.0039	CcSEcCtD
Tiludronate—Nausea—Nilutamide—prostate cancer	0.00154	0.00389	CcSEcCtD
Tiludronate—Nausea—Flutamide—prostate cancer	0.00153	0.00387	CcSEcCtD
Tiludronate—Dizziness—Degarelix—prostate cancer	0.00153	0.00387	CcSEcCtD
Tiludronate—Gastrointestinal pain—Bicalutamide—prostate cancer	0.00153	0.00386	CcSEcCtD
Tiludronate—Back pain—Conjugated Estrogens—prostate cancer	0.00152	0.00386	CcSEcCtD
Tiludronate—Headache—Estradiol valerate/Dienogest—prostate cancer	0.00152	0.00385	CcSEcCtD
Tiludronate—Diarrhoea—Cabazitaxel—prostate cancer	0.00149	0.00377	CcSEcCtD
Tiludronate—Abdominal pain—Bicalutamide—prostate cancer	0.00148	0.00373	CcSEcCtD
Tiludronate—Rhinitis—Estradiol—prostate cancer	0.00145	0.00368	CcSEcCtD
Tiludronate—Headache—Degarelix—prostate cancer	0.00145	0.00366	CcSEcCtD
Tiludronate—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.00144	0.00365	CcSEcCtD
Tiludronate—Dizziness—Cabazitaxel—prostate cancer	0.00144	0.00364	CcSEcCtD
Tiludronate—Vertigo—Conjugated Estrogens—prostate cancer	0.00142	0.00358	CcSEcCtD
Tiludronate—Nausea—Degarelix—prostate cancer	0.00137	0.00347	CcSEcCtD
Tiludronate—Headache—Cabazitaxel—prostate cancer	0.00136	0.00345	CcSEcCtD
Tiludronate—Myalgia—Goserelin—prostate cancer	0.00135	0.00343	CcSEcCtD
Tiludronate—Arthralgia—Goserelin—prostate cancer	0.00135	0.00343	CcSEcCtD
Tiludronate—Rhinitis—Mitoxantrone—prostate cancer	0.00135	0.00343	CcSEcCtD
Tiludronate—Myalgia—Conjugated Estrogens—prostate cancer	0.00134	0.0034	CcSEcCtD
Tiludronate—Arthralgia—Conjugated Estrogens—prostate cancer	0.00134	0.0034	CcSEcCtD
Tiludronate—Asthenia—Bicalutamide—prostate cancer	0.00134	0.00339	CcSEcCtD
Tiludronate—Bone pain—Epirubicin—prostate cancer	0.00131	0.00331	CcSEcCtD
Tiludronate—Nausea—Cabazitaxel—prostate cancer	0.00129	0.00327	CcSEcCtD
Tiludronate—Gastrointestinal pain—Ethinyl Estradiol—prostate cancer	0.00129	0.00327	CcSEcCtD
Tiludronate—Diarrhoea—Bicalutamide—prostate cancer	0.00128	0.00323	CcSEcCtD
Tiludronate—Abdominal pain—Ethinyl Estradiol—prostate cancer	0.00125	0.00316	CcSEcCtD
Tiludronate—Dizziness—Bicalutamide—prostate cancer	0.00123	0.00312	CcSEcCtD
Tiludronate—Back pain—Estradiol—prostate cancer	0.00122	0.00309	CcSEcCtD
Tiludronate—Influenza like illness—Epirubicin—prostate cancer	0.00122	0.00308	CcSEcCtD
Tiludronate—Bone pain—Doxorubicin—prostate cancer	0.00121	0.00306	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Goserelin—prostate cancer	0.00118	0.00299	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Conjugated Estrogens—prostate cancer	0.00117	0.00297	CcSEcCtD
Tiludronate—Headache—Bicalutamide—prostate cancer	0.00117	0.00296	CcSEcCtD
Tiludronate—Dyspepsia—Goserelin—prostate cancer	0.00114	0.00289	CcSEcCtD
Tiludronate—Back pain—Mitoxantrone—prostate cancer	0.00114	0.00288	CcSEcCtD
Tiludronate—Vertigo—Estradiol—prostate cancer	0.00113	0.00287	CcSEcCtD
Tiludronate—Dyspepsia—Conjugated Estrogens—prostate cancer	0.00113	0.00287	CcSEcCtD
Tiludronate—Asthenia—Ethinyl Estradiol—prostate cancer	0.00113	0.00287	CcSEcCtD
Tiludronate—Influenza like illness—Doxorubicin—prostate cancer	0.00113	0.00285	CcSEcCtD
Tiludronate—Pain—Goserelin—prostate cancer	0.00111	0.00281	CcSEcCtD
Tiludronate—Nausea—Bicalutamide—prostate cancer	0.00111	0.00281	CcSEcCtD
Tiludronate—Pain—Conjugated Estrogens—prostate cancer	0.0011	0.00278	CcSEcCtD
Tiludronate—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.00108	0.00273	CcSEcCtD
Tiludronate—Myalgia—Estradiol—prostate cancer	0.00107	0.00272	CcSEcCtD
Tiludronate—Arthralgia—Estradiol—prostate cancer	0.00107	0.00272	CcSEcCtD
Tiludronate—Gastrointestinal pain—Goserelin—prostate cancer	0.00106	0.00269	CcSEcCtD
Tiludronate—Gastrointestinal pain—Conjugated Estrogens—prostate cancer	0.00105	0.00266	CcSEcCtD
Tiludronate—Dizziness—Ethinyl Estradiol—prostate cancer	0.00104	0.00264	CcSEcCtD
Tiludronate—Abdominal pain—Goserelin—prostate cancer	0.00103	0.0026	CcSEcCtD
Tiludronate—Abdominal pain—Conjugated Estrogens—prostate cancer	0.00102	0.00257	CcSEcCtD
Tiludronate—Arthralgia—Mitoxantrone—prostate cancer	0.001	0.00253	CcSEcCtD
Tiludronate—Myalgia—Mitoxantrone—prostate cancer	0.001	0.00253	CcSEcCtD
Tiludronate—Headache—Ethinyl Estradiol—prostate cancer	0.000988	0.0025	CcSEcCtD
Tiludronate—Back pain—Etoposide—prostate cancer	0.000945	0.00239	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Estradiol—prostate cancer	0.000938	0.00237	CcSEcCtD
Tiludronate—Nausea—Ethinyl Estradiol—prostate cancer	0.000937	0.00237	CcSEcCtD
Tiludronate—Rhinitis—Docetaxel—prostate cancer	0.000935	0.00237	CcSEcCtD
Tiludronate—Asthenia—Goserelin—prostate cancer	0.000931	0.00236	CcSEcCtD
Tiludronate—Asthenia—Conjugated Estrogens—prostate cancer	0.000923	0.00234	CcSEcCtD
Tiludronate—Dyspepsia—Estradiol—prostate cancer	0.000906	0.00229	CcSEcCtD
Tiludronate—Rhinitis—Capecitabine—prostate cancer	0.000906	0.00229	CcSEcCtD
Tiludronate—Diarrhoea—Goserelin—prostate cancer	0.000888	0.00225	CcSEcCtD
Tiludronate—Pain—Estradiol—prostate cancer	0.00088	0.00223	CcSEcCtD
Tiludronate—Diarrhoea—Conjugated Estrogens—prostate cancer	0.00088	0.00223	CcSEcCtD
Tiludronate—Vertigo—Etoposide—prostate cancer	0.000878	0.00222	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Mitoxantrone—prostate cancer	0.000874	0.00221	CcSEcCtD
Tiludronate—Dizziness—Goserelin—prostate cancer	0.000858	0.00217	CcSEcCtD
Tiludronate—Dizziness—Conjugated Estrogens—prostate cancer	0.00085	0.00215	CcSEcCtD
Tiludronate—Dyspepsia—Mitoxantrone—prostate cancer	0.000844	0.00214	CcSEcCtD
Tiludronate—Gastrointestinal pain—Estradiol—prostate cancer	0.000842	0.00213	CcSEcCtD
Tiludronate—Pain—Mitoxantrone—prostate cancer	0.00082	0.00208	CcSEcCtD
Tiludronate—Abdominal pain—Estradiol—prostate cancer	0.000814	0.00206	CcSEcCtD
Tiludronate—Headache—Goserelin—prostate cancer	0.000813	0.00206	CcSEcCtD
Tiludronate—Headache—Conjugated Estrogens—prostate cancer	0.000806	0.00204	CcSEcCtD
Tiludronate—Back pain—Docetaxel—prostate cancer	0.000786	0.00199	CcSEcCtD
Tiludronate—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000784	0.00199	CcSEcCtD
Tiludronate—Nausea—Goserelin—prostate cancer	0.000771	0.00195	CcSEcCtD
Tiludronate—Nausea—Conjugated Estrogens—prostate cancer	0.000764	0.00193	CcSEcCtD
Tiludronate—Back pain—Capecitabine—prostate cancer	0.000761	0.00193	CcSEcCtD
Tiludronate—Abdominal pain—Mitoxantrone—prostate cancer	0.000758	0.00192	CcSEcCtD
Tiludronate—Asthenia—Estradiol—prostate cancer	0.000738	0.00187	CcSEcCtD
Tiludronate—Vertigo—Capecitabine—prostate cancer	0.000706	0.00179	CcSEcCtD
Tiludronate—Diarrhoea—Estradiol—prostate cancer	0.000704	0.00178	CcSEcCtD
Tiludronate—Arthralgia—Docetaxel—prostate cancer	0.000691	0.00175	CcSEcCtD
Tiludronate—Myalgia—Docetaxel—prostate cancer	0.000691	0.00175	CcSEcCtD
Tiludronate—Asthenia—Mitoxantrone—prostate cancer	0.000688	0.00174	CcSEcCtD
Tiludronate—Pain—Etoposide—prostate cancer	0.000682	0.00173	CcSEcCtD
Tiludronate—Dizziness—Estradiol—prostate cancer	0.000681	0.00172	CcSEcCtD
Tiludronate—Myalgia—Capecitabine—prostate cancer	0.000669	0.00169	CcSEcCtD
Tiludronate—Arthralgia—Capecitabine—prostate cancer	0.000669	0.00169	CcSEcCtD
Tiludronate—Diarrhoea—Mitoxantrone—prostate cancer	0.000656	0.00166	CcSEcCtD
Tiludronate—Gastrointestinal pain—Etoposide—prostate cancer	0.000652	0.00165	CcSEcCtD
Tiludronate—Headache—Estradiol—prostate cancer	0.000645	0.00163	CcSEcCtD
Tiludronate—Rhinitis—Epirubicin—prostate cancer	0.000631	0.0016	CcSEcCtD
Tiludronate—Abdominal pain—Etoposide—prostate cancer	0.000631	0.0016	CcSEcCtD
Tiludronate—Vertigo—Prednisone—prostate cancer	0.000629	0.00159	CcSEcCtD
Tiludronate—Nausea—Estradiol—prostate cancer	0.000611	0.00155	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000604	0.00153	CcSEcCtD
Tiludronate—Headache—Mitoxantrone—prostate cancer	0.000601	0.00152	CcSEcCtD
Tiludronate—Myalgia—Prednisone—prostate cancer	0.000596	0.00151	CcSEcCtD
Tiludronate—Arthralgia—Prednisone—prostate cancer	0.000596	0.00151	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.000585	0.00148	CcSEcCtD
Tiludronate—Rhinitis—Doxorubicin—prostate cancer	0.000584	0.00148	CcSEcCtD
Tiludronate—Dyspepsia—Docetaxel—prostate cancer	0.000583	0.00148	CcSEcCtD
Tiludronate—Asthenia—Etoposide—prostate cancer	0.000572	0.00145	CcSEcCtD
Tiludronate—Nausea—Mitoxantrone—prostate cancer	0.00057	0.00144	CcSEcCtD
Tiludronate—Pain—Docetaxel—prostate cancer	0.000567	0.00144	CcSEcCtD
Tiludronate—Dyspepsia—Capecitabine—prostate cancer	0.000565	0.00143	CcSEcCtD
Tiludronate—Pain—Capecitabine—prostate cancer	0.000549	0.00139	CcSEcCtD
Tiludronate—Diarrhoea—Etoposide—prostate cancer	0.000546	0.00138	CcSEcCtD
Tiludronate—Gastrointestinal pain—Docetaxel—prostate cancer	0.000542	0.00137	CcSEcCtD
Tiludronate—Back pain—Epirubicin—prostate cancer	0.00053	0.00134	CcSEcCtD
Tiludronate—Dizziness—Etoposide—prostate cancer	0.000527	0.00134	CcSEcCtD
Tiludronate—Gastrointestinal pain—Capecitabine—prostate cancer	0.000525	0.00133	CcSEcCtD
Tiludronate—Abdominal pain—Docetaxel—prostate cancer	0.000524	0.00133	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Prednisone—prostate cancer	0.000521	0.00132	CcSEcCtD
Tiludronate—Abdominal pain—Capecitabine—prostate cancer	0.000507	0.00128	CcSEcCtD
Tiludronate—Dyspepsia—Prednisone—prostate cancer	0.000503	0.00127	CcSEcCtD
Tiludronate—Headache—Etoposide—prostate cancer	0.0005	0.00127	CcSEcCtD
Tiludronate—Vertigo—Epirubicin—prostate cancer	0.000492	0.00125	CcSEcCtD
Tiludronate—Back pain—Doxorubicin—prostate cancer	0.00049	0.00124	CcSEcCtD
Tiludronate—Asthenia—Docetaxel—prostate cancer	0.000476	0.0012	CcSEcCtD
Tiludronate—Nausea—Etoposide—prostate cancer	0.000474	0.0012	CcSEcCtD
Tiludronate—Gastrointestinal pain—Prednisone—prostate cancer	0.000467	0.00118	CcSEcCtD
Tiludronate—Myalgia—Epirubicin—prostate cancer	0.000466	0.00118	CcSEcCtD
Tiludronate—Arthralgia—Epirubicin—prostate cancer	0.000466	0.00118	CcSEcCtD
Tiludronate—Asthenia—Capecitabine—prostate cancer	0.00046	0.00117	CcSEcCtD
Tiludronate—Vertigo—Doxorubicin—prostate cancer	0.000455	0.00115	CcSEcCtD
Tiludronate—Diarrhoea—Docetaxel—prostate cancer	0.000454	0.00115	CcSEcCtD
Tiludronate—Abdominal pain—Prednisone—prostate cancer	0.000452	0.00114	CcSEcCtD
Tiludronate—Diarrhoea—Capecitabine—prostate cancer	0.000439	0.00111	CcSEcCtD
Tiludronate—Dizziness—Docetaxel—prostate cancer	0.000438	0.00111	CcSEcCtD
Tiludronate—Arthralgia—Doxorubicin—prostate cancer	0.000432	0.00109	CcSEcCtD
Tiludronate—Myalgia—Doxorubicin—prostate cancer	0.000432	0.00109	CcSEcCtD
Tiludronate—Dizziness—Capecitabine—prostate cancer	0.000424	0.00107	CcSEcCtD
Tiludronate—Headache—Docetaxel—prostate cancer	0.000415	0.00105	CcSEcCtD
Tiludronate—Asthenia—Prednisone—prostate cancer	0.00041	0.00104	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Epirubicin—prostate cancer	0.000407	0.00103	CcSEcCtD
Tiludronate—Headache—Capecitabine—prostate cancer	0.000402	0.00102	CcSEcCtD
Tiludronate—Nausea—Docetaxel—prostate cancer	0.000394	0.000997	CcSEcCtD
Tiludronate—Dyspepsia—Epirubicin—prostate cancer	0.000394	0.000996	CcSEcCtD
Tiludronate—Diarrhoea—Prednisone—prostate cancer	0.000391	0.00099	CcSEcCtD
Tiludronate—Pain—Epirubicin—prostate cancer	0.000382	0.000968	CcSEcCtD
Tiludronate—Nausea—Capecitabine—prostate cancer	0.000381	0.000965	CcSEcCtD
Tiludronate—Dizziness—Prednisone—prostate cancer	0.000378	0.000957	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Doxorubicin—prostate cancer	0.000377	0.000954	CcSEcCtD
Tiludronate—Gastrointestinal pain—Epirubicin—prostate cancer	0.000366	0.000926	CcSEcCtD
Tiludronate—Dyspepsia—Doxorubicin—prostate cancer	0.000364	0.000922	CcSEcCtD
Tiludronate—Headache—Prednisone—prostate cancer	0.000358	0.000907	CcSEcCtD
Tiludronate—Pain—Doxorubicin—prostate cancer	0.000354	0.000896	CcSEcCtD
Tiludronate—Abdominal pain—Epirubicin—prostate cancer	0.000353	0.000895	CcSEcCtD
Tiludronate—Nausea—Prednisone—prostate cancer	0.00034	0.00086	CcSEcCtD
Tiludronate—Gastrointestinal pain—Doxorubicin—prostate cancer	0.000338	0.000856	CcSEcCtD
Tiludronate—Abdominal pain—Doxorubicin—prostate cancer	0.000327	0.000828	CcSEcCtD
Tiludronate—Asthenia—Epirubicin—prostate cancer	0.000321	0.000812	CcSEcCtD
Tiludronate—Diarrhoea—Epirubicin—prostate cancer	0.000306	0.000774	CcSEcCtD
Tiludronate—Asthenia—Doxorubicin—prostate cancer	0.000297	0.000751	CcSEcCtD
Tiludronate—Dizziness—Epirubicin—prostate cancer	0.000296	0.000749	CcSEcCtD
Tiludronate—Diarrhoea—Doxorubicin—prostate cancer	0.000283	0.000717	CcSEcCtD
Tiludronate—Headache—Epirubicin—prostate cancer	0.00028	0.000709	CcSEcCtD
Tiludronate—Dizziness—Doxorubicin—prostate cancer	0.000274	0.000693	CcSEcCtD
Tiludronate—Nausea—Epirubicin—prostate cancer	0.000266	0.000672	CcSEcCtD
Tiludronate—Headache—Doxorubicin—prostate cancer	0.000259	0.000656	CcSEcCtD
Tiludronate—Nausea—Doxorubicin—prostate cancer	0.000246	0.000622	CcSEcCtD
Tiludronate—PTPN1—Signaling Pathways—PDE4D—prostate cancer	0.000238	0.000572	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—HSPA1A—prostate cancer	0.000238	0.000571	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—MAP3K7—prostate cancer	0.000237	0.000568	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—NOS3—prostate cancer	0.000234	0.000561	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—HIST1H4H—prostate cancer	0.000232	0.000557	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—HIST1H4H—prostate cancer	0.000232	0.000557	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—KRAS—prostate cancer	0.00023	0.000552	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CASP9—prostate cancer	0.000228	0.000548	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—FGF10—prostate cancer	0.000228	0.000546	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—JAK2—prostate cancer	0.000227	0.000545	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—GNG5—prostate cancer	0.000227	0.000544	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—GNG5—prostate cancer	0.000227	0.000544	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—CREBBP—prostate cancer	0.000226	0.000543	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PRKCQ—prostate cancer	0.000221	0.000531	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—VAV3—prostate cancer	0.00022	0.000527	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—PIK3CB—prostate cancer	0.000216	0.000518	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—ITPR1—prostate cancer	0.000213	0.000511	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—PIK3CA—prostate cancer	0.000211	0.000507	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—FGF10—prostate cancer	0.00021	0.000504	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—AKT1—prostate cancer	0.000209	0.0005	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—TGFBR2—prostate cancer	0.0002	0.00048	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IL18—prostate cancer	0.0002	0.000479	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—IL2—prostate cancer	0.000198	0.000476	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PTHLH—prostate cancer	0.000197	0.000474	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TGFBR1—prostate cancer	0.000197	0.000474	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PTHLH—prostate cancer	0.000197	0.000474	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TGFBR1—prostate cancer	0.000197	0.000474	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—ITPR1—prostate cancer	0.000197	0.000472	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—AKR1C3—prostate cancer	0.000194	0.000466	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—AKR1C3—prostate cancer	0.000194	0.000466	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PDGFRB—prostate cancer	0.000193	0.000464	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PRKACB—prostate cancer	0.000193	0.000464	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PRKACB—prostate cancer	0.000193	0.000464	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PPP3CA—prostate cancer	0.000188	0.000452	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—THBS1—prostate cancer	0.000188	0.000452	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PPP3CA—prostate cancer	0.000188	0.000452	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—THBS1—prostate cancer	0.000188	0.000452	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—IL6—prostate cancer	0.000187	0.000449	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—ANXA1—prostate cancer	0.000186	0.000445	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—ANXA1—prostate cancer	0.000186	0.000445	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—ERBB3—prostate cancer	0.000183	0.000439	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—FGFR2—prostate cancer	0.000183	0.000438	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PRKCZ—prostate cancer	0.000182	0.000437	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PRKCZ—prostate cancer	0.000182	0.000437	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—LPL—prostate cancer	0.00018	0.000433	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PDGFRB—prostate cancer	0.000179	0.000429	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—EP300—prostate cancer	0.000178	0.000427	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PARP1—prostate cancer	0.000176	0.000422	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—FGFR4—prostate cancer	0.000176	0.000422	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—FGFR4—prostate cancer	0.000176	0.000422	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PARP1—prostate cancer	0.000176	0.000422	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CALCA—prostate cancer	0.000174	0.000417	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CALCA—prostate cancer	0.000174	0.000417	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—SRC—prostate cancer	0.000173	0.000415	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—ERCC2—prostate cancer	0.000173	0.000414	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CXCL12—prostate cancer	0.00017	0.000407	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CXCL12—prostate cancer	0.00017	0.000407	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—ERBB3—prostate cancer	0.000169	0.000405	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—FGFR2—prostate cancer	0.000169	0.000405	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—VEGFA—prostate cancer	0.000168	0.000404	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—BCL2L1—prostate cancer	0.000168	0.000404	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—MTHFR—prostate cancer	0.000162	0.00039	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—TERT—prostate cancer	0.000162	0.000388	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—TLR4—prostate cancer	0.00016	0.000385	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CASP9—prostate cancer	0.00016	0.000384	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CASP9—prostate cancer	0.00016	0.000384	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PRKCQ—prostate cancer	0.000155	0.000372	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—NGFR—prostate cancer	0.000155	0.000372	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PRKCQ—prostate cancer	0.000155	0.000372	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—NGFR—prostate cancer	0.000155	0.000372	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—HIF1A—prostate cancer	0.000155	0.000372	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—TGFB1—prostate cancer	0.000155	0.000371	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—ICAM1—prostate cancer	0.000154	0.000369	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MAP3K7—prostate cancer	0.000153	0.000367	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MAP3K7—prostate cancer	0.000153	0.000367	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—BAD—prostate cancer	0.000152	0.000366	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CAV1—prostate cancer	0.00015	0.000359	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—FGF10—prostate cancer	0.000147	0.000353	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—FGF10—prostate cancer	0.000147	0.000353	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—EGF—prostate cancer	0.000146	0.00035	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IRS1—prostate cancer	0.000146	0.00035	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—ADRB2—prostate cancer	0.000146	0.000349	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—ADRB2—prostate cancer	0.000146	0.000349	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—KRAS—prostate cancer	0.000143	0.000344	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—VAV3—prostate cancer	0.000142	0.000341	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—VAV3—prostate cancer	0.000142	0.000341	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—GSK3B—prostate cancer	0.000142	0.00034	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—BAD—prostate cancer	0.000141	0.000338	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TGFBR2—prostate cancer	0.00014	0.000336	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TGFBR2—prostate cancer	0.00014	0.000336	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—ITPR1—prostate cancer	0.000138	0.000331	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—ITPR1—prostate cancer	0.000138	0.000331	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CREBBP—prostate cancer	0.000137	0.000329	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—APC—prostate cancer	0.000136	0.000327	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CDH1—prostate cancer	0.000136	0.000326	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—EGF—prostate cancer	0.000135	0.000324	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—IRS1—prostate cancer	0.000135	0.000324	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IGF1R—prostate cancer	0.000132	0.000316	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IGF1R—prostate cancer	0.000132	0.000316	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—PIK3CA—prostate cancer	0.000132	0.000316	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—GSK3B—prostate cancer	0.000131	0.000314	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—MAP2K1—prostate cancer	0.000131	0.000314	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PIK3CD—prostate cancer	0.00013	0.000312	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—INS—prostate cancer	0.000129	0.00031	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—TP53—prostate cancer	0.000127	0.000305	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CREBBP—prostate cancer	0.000126	0.000303	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—LPL—prostate cancer	0.000126	0.000303	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—LPL—prostate cancer	0.000126	0.000303	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PDGFRB—prostate cancer	0.000125	0.0003	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PDGFRB—prostate cancer	0.000125	0.0003	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—FGF2—prostate cancer	0.000124	0.000298	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—ITGB3—prostate cancer	0.000122	0.000293	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—ITGB3—prostate cancer	0.000122	0.000293	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—MAP2K1—prostate cancer	0.000121	0.00029	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PIK3CD—prostate cancer	0.00012	0.000288	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—JAK2—prostate cancer	0.000119	0.000286	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—SERPINE1—prostate cancer	0.000119	0.000285	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—ERBB3—prostate cancer	0.000118	0.000284	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—ERBB3—prostate cancer	0.000118	0.000284	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—FGFR2—prostate cancer	0.000118	0.000283	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—FGFR2—prostate cancer	0.000118	0.000283	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—BCL2—prostate cancer	0.000118	0.000283	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—MDM2—prostate cancer	0.000116	0.000279	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—FGF2—prostate cancer	0.000115	0.000275	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—ERBB2—prostate cancer	0.000115	0.000275	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TERT—prostate cancer	0.000113	0.000272	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TERT—prostate cancer	0.000113	0.000272	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—NOS3—prostate cancer	0.000113	0.000272	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PIK3CB—prostate cancer	0.000113	0.000272	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—JAK2—prostate cancer	0.00011	0.000264	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—HIF1A—prostate cancer	0.000108	0.00026	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—HIF1A—prostate cancer	0.000108	0.00026	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—AKT1—prostate cancer	0.000107	0.000258	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—MDM2—prostate cancer	0.000107	0.000258	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CDKN1B—prostate cancer	0.000106	0.000255	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—ERBB2—prostate cancer	0.000106	0.000254	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—LEP—prostate cancer	0.000106	0.000254	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—LEP—prostate cancer	0.000106	0.000254	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CAV1—prostate cancer	0.000105	0.000252	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CAV1—prostate cancer	0.000105	0.000252	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PIK3CB—prostate cancer	0.000104	0.000251	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IL2—prostate cancer	0.000104	0.000249	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—KDR—prostate cancer	0.000104	0.000249	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—KDR—prostate cancer	0.000104	0.000249	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PTGS2—prostate cancer	0.000104	0.000248	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—ESR1—prostate cancer	0.000101	0.000242	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—ESR1—prostate cancer	0.000101	0.000242	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CTNNB1—prostate cancer	0.0001	0.000241	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—BAD—prostate cancer	9.86e-05	0.000237	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—BAD—prostate cancer	9.86e-05	0.000237	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CDKN1B—prostate cancer	9.81e-05	0.000235	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CDKN1A—prostate cancer	9.8e-05	0.000235	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PTEN—prostate cancer	9.78e-05	0.000235	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—APC—prostate cancer	9.55e-05	0.000229	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PIK3CG—prostate cancer	9.55e-05	0.000229	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PIK3CG—prostate cancer	9.55e-05	0.000229	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—APC—prostate cancer	9.55e-05	0.000229	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—EGF—prostate cancer	9.44e-05	0.000227	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IRS1—prostate cancer	9.44e-05	0.000227	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—EGF—prostate cancer	9.44e-05	0.000227	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IRS1—prostate cancer	9.44e-05	0.000227	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—EP300—prostate cancer	9.33e-05	0.000224	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CTNNB1—prostate cancer	9.26e-05	0.000222	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—GSK3B—prostate cancer	9.16e-05	0.00022	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—GSK3B—prostate cancer	9.16e-05	0.00022	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—SRC—prostate cancer	9.07e-05	0.000218	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CDKN1A—prostate cancer	9.05e-05	0.000217	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—INS—prostate cancer	9.04e-05	0.000217	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—INS—prostate cancer	9.04e-05	0.000217	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PTEN—prostate cancer	9.03e-05	0.000217	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CREBBP—prostate cancer	8.85e-05	0.000213	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CREBBP—prostate cancer	8.85e-05	0.000213	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—STAT3—prostate cancer	8.75e-05	0.00021	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IGF1—prostate cancer	8.74e-05	0.00021	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IGF1—prostate cancer	8.74e-05	0.00021	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—EP300—prostate cancer	8.61e-05	0.000207	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MAP2K1—prostate cancer	8.45e-05	0.000203	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MAP2K1—prostate cancer	8.45e-05	0.000203	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PIK3CD—prostate cancer	8.39e-05	0.000201	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PIK3CD—prostate cancer	8.39e-05	0.000201	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—SRC—prostate cancer	8.37e-05	0.000201	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—SERPINE1—prostate cancer	8.3e-05	0.000199	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—SERPINE1—prostate cancer	8.3e-05	0.000199	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—STAT3—prostate cancer	8.07e-05	0.000194	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—FGF2—prostate cancer	8.04e-05	0.000193	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—FGF2—prostate cancer	8.04e-05	0.000193	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—EGFR—prostate cancer	7.95e-05	0.000191	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—NOS3—prostate cancer	7.93e-05	0.00019	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—NOS3—prostate cancer	7.93e-05	0.00019	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—JAK2—prostate cancer	7.7e-05	0.000185	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—JAK2—prostate cancer	7.7e-05	0.000185	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MDM2—prostate cancer	7.52e-05	0.000181	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MDM2—prostate cancer	7.52e-05	0.000181	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—KRAS—prostate cancer	7.51e-05	0.00018	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—MYC—prostate cancer	7.5e-05	0.00018	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—TGFB1—prostate cancer	7.49e-05	0.00018	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—ERBB2—prostate cancer	7.41e-05	0.000178	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—ERBB2—prostate cancer	7.41e-05	0.000178	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—EGFR—prostate cancer	7.34e-05	0.000176	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PIK3CB—prostate cancer	7.32e-05	0.000176	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PIK3CB—prostate cancer	7.32e-05	0.000176	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CXCL8—prostate cancer	7.03e-05	0.000169	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CXCL8—prostate cancer	7.03e-05	0.000169	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—KRAS—prostate cancer	6.93e-05	0.000166	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PIK3CA—prostate cancer	6.9e-05	0.000166	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CDKN1B—prostate cancer	6.87e-05	0.000165	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CDKN1B—prostate cancer	6.87e-05	0.000165	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CASP3—prostate cancer	6.73e-05	0.000162	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CASP3—prostate cancer	6.73e-05	0.000162	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IL2—prostate cancer	6.72e-05	0.000161	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IL2—prostate cancer	6.72e-05	0.000161	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CCND1—prostate cancer	6.55e-05	0.000157	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CCND1—prostate cancer	6.55e-05	0.000157	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CTNNB1—prostate cancer	6.49e-05	0.000156	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CTNNB1—prostate cancer	6.49e-05	0.000156	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PIK3CA—prostate cancer	6.37e-05	0.000153	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MMP9—prostate cancer	6.36e-05	0.000153	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MMP9—prostate cancer	6.36e-05	0.000153	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CDKN1A—prostate cancer	6.34e-05	0.000152	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CDKN1A—prostate cancer	6.34e-05	0.000152	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PTEN—prostate cancer	6.32e-05	0.000152	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PTEN—prostate cancer	6.32e-05	0.000152	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IL6—prostate cancer	6.11e-05	0.000147	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—EP300—prostate cancer	6.03e-05	0.000145	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—EP300—prostate cancer	6.03e-05	0.000145	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—SRC—prostate cancer	5.86e-05	0.000141	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—SRC—prostate cancer	5.86e-05	0.000141	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—VEGFA—prostate cancer	5.71e-05	0.000137	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—VEGFA—prostate cancer	5.71e-05	0.000137	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—STAT3—prostate cancer	5.65e-05	0.000136	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—STAT3—prostate cancer	5.65e-05	0.000136	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—IL6—prostate cancer	5.64e-05	0.000135	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—AKT1—prostate cancer	5.64e-05	0.000135	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MYC—prostate cancer	5.25e-05	0.000126	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MYC—prostate cancer	5.25e-05	0.000126	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TGFB1—prostate cancer	5.24e-05	0.000126	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TGFB1—prostate cancer	5.24e-05	0.000126	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—AKT1—prostate cancer	5.2e-05	0.000125	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—EGFR—prostate cancer	5.14e-05	0.000123	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—EGFR—prostate cancer	5.14e-05	0.000123	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—KRAS—prostate cancer	4.85e-05	0.000117	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—KRAS—prostate cancer	4.85e-05	0.000117	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PIK3CA—prostate cancer	4.46e-05	0.000107	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PIK3CA—prostate cancer	4.46e-05	0.000107	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TP53—prostate cancer	4.32e-05	0.000104	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TP53—prostate cancer	4.32e-05	0.000104	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IL6—prostate cancer	3.95e-05	9.48e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IL6—prostate cancer	3.95e-05	9.48e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—AKT1—prostate cancer	3.64e-05	8.75e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—AKT1—prostate cancer	3.64e-05	8.75e-05	CbGpPWpGaD
